These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26827569)

  • 1. [Vitamin K antagonists overdose].
    Groszek B; Piszczek P
    Przegl Lek; 2015; 72(9):468-71. PubMed ID: 26827569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overdose in Vitamin K antagonists administration in Dakar: epidemiological, clinical and evolutionary aspects].
    Dia K; Sarr SA; Mboup MC; Ba DM; Fall PD
    Pan Afr Med J; 2016; 24():186. PubMed ID: 27795783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
    Steib A; Barre J; Mertes M; Morel MH; Nathan N; Ozier Y; Treger M; Samama CM
    J Thromb Haemost; 2010 Mar; 8(3):499-503. PubMed ID: 19912513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
    Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
    Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of anticoagulation with vitamin K antagonists in acute stroke patients with atrial fibrillation--Hungarian results].
    Sas A; Csontos K; Lovász R; Valikovics A
    Ideggyogy Sz; 2015 Jan; 68(1-2):47-51. PubMed ID: 25842916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
    Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
    Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
    Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
    Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
    Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
    Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to optimal dosing of vitamin K antagonists.
    Witt DM
    Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
    Jończyk-Skórka K; Śliwczyńska-Rodziewicz D; Jarmak A; Kowalski J
    Pol Merkur Lekarski; 2015 Mar; 38(225):144-9. PubMed ID: 25815614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and new anticoagulants.
    Harbrecht U
    Hamostaseologie; 2011 Feb; 31(1):21-7. PubMed ID: 21311820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists].
    Cambus JP; Magnin D; Ambid-Lacombe C; Bura A; Desgrippes F; Schneller JM; Benhamou Y; Flaujac C; Horellou MH; De Raucourt E; Kaczan D; Astoul JM; Siguret V
    Rev Med Interne; 2013 Sep; 34(9):515-21. PubMed ID: 23523077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
    Karrowni W; Wang TY; Chen AY; Thomas L; Saucedo JF; El Accaoui RN
    Heart; 2015 Feb; 101(4):264-70. PubMed ID: 25336230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin Poisoning with Delayed Rebound Toxicity.
    Berling I; Mostafa A; Grice JE; Roberts MS; Isbister GK
    J Emerg Med; 2017 Feb; 52(2):194-196. PubMed ID: 27838137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.